Advancing Scientific Innovation
First in class drug device combination to treat nuisance bleeding in patients on anticoagulants
According to a recent survey by the National Blood Clot Alliance (https://www.stoptheclot.org/
Bio 54 is developing a novel drug/device combination called BXP154 to treat external bleeding from minor wounds in anticoagulant patients. This is a product with the potential to improve the life experience for patients on anticoagulants, and provides a new exciting opportunity in the treatment market.
Bio 54 is an affiliate company of 501 Ventures, LLC (a life science accelerator)
A Better Solution
Current standard of care for these prolonged bleeding episodes is basic wound care, which can take hours or require a hospital visit.
Hand-held Drug Delivery
Bio 54 is developing a novel, hand-held drug delivery device for patients to stop nuisance bleeding events comfortably at home.
Safe & Effective
There is an unmet need for patients on blood thinners who experience nuisance external bleeding
Medicare and Medicaid anticoagulation claims in 20191
Combined Medicare and Medicaid anticoagulation claims increase from 2014 to 20191
Combined Medicare and Medicaid anticoagulation spending in 20191
Emergency department visits resulting from bleeding from oral anticoagulants in 20172
1 Angela Duvalyan, Ambarish Pandey, Muthiah Vaduganathan, Utibe R. Essien, Ethan A. Halm, Gregg C. Fonarow and Andrew Sumarsono. (2021) “Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019.” Journal of the American Heart Association, 10(24). https://www.ahajournals.org/doi/10.1161/JAHA.121.022644
2 Geller AI, Shehab N, Lovegrove MC, Rose KO, Weidle NJ, Goring SK, Budnitz DS. Emergency Visits for Oral Anticoagulant Bleeding external icon J Gen Intern Med 2019 Oct 29.